- Home
- NTRB vs HYI Comparison
NTRB vs HYI Comparison
Compare NTRB & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTRB | HYI |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.0M | 252.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NTRB | HYI |
|---|---|---|
| Price | $4.22 | $11.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.9K | ★ 50.6K |
| Earning Date | 12-11-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.59% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,278,321.00 | N/A |
| Revenue This Year | $30.17 | N/A |
| Revenue Next Year | $3,394.36 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.69 | N/A |
| 52 Week Low | $4.06 | $10.99 |
| 52 Week High | $11.68 | $12.24 |
Technical Indicators
Market Signals| Indicator | NTRB | HYI |
|---|---|---|
| Relative Strength Index (RSI) | 38.00 | 55.96 |
| Support Level | $4.06 | $11.17 |
| Resistance Level | $4.49 | $11.21 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 1.09 | 70.00 |
Price Performance
Historical ComparisonAbout NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.